Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs eMI Aesthetics

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and eMI Aesthetics head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 144 · Grade C

eMI Aesthetics

Visit eMI Aesthetics Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 71 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make eMI Aesthetics a bad call — it's best for readers interested in supported virtual care who can verify the exact medication, full subscription charge and cancellation terms. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
78
Supply Reliability
95
71
Transparency
90
48
Access Breadth
93
92
Clinical Oversight
92
70
Track Record
88
65
CoreAge RxBrief Score 94 · 71eMI Aesthetics

Price, coverage & the tracker

CoreAge RxeMI Aesthetics
Brief Score94/100 (A)71/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm medication and care total

Program advertised from $179/month; semaglutide from $119 and oral semaglutide from $146.

Medication figures do not establish a complete billing period, formulation or selected-plan total.

Full price details

Current semaglutide formulation and complete quote unknown; medication page lists from $119 and oral from $146 without a complete period/plan; earlier listing: From $179/mo (all doses, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm medication and care total

Tirzepatide from $102 and branded Zepbound from $1,399 are separate listings.

Confirm the formulation, supplied period and full selected-plan charge.

Full price details

Current tirzepatide formulation and complete quote unknown; page lists from $102 and branded Zepbound from $1,399 without establishing the applicable plan; earlier listing: Not disclosed

CoverageUS only; restrictions by state, confirmed at intakeAdvertises eligible-patient access in all fifty states, subject to clinical and state requirements; confirm the selected treatment
Brand-name accessNot confirmedNamed Ozempic and Zepbound choices are advertised; the selected brand, formulation, dispensing pharmacy and full charge need confirmation.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

eMI Aesthetics: Generic program starts at $179/month; medication listings use separate starting figures without a complete selected-plan period or charge.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.